TCBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Texas Capital Bancshares Inc (TCBI) does not present a compelling buy opportunity for a beginner, long-term investor at this moment. While the company has shown strong financial performance and hedge funds are increasing their positions, the lack of recent positive news, mixed analyst ratings, and technical indicators suggesting potential short-term downside make it prudent to hold off on investing right now.
The stock is currently in a bullish trend with moving averages showing SMA_5 > SMA_20 > SMA_200. The MACD is positive at 0.921, but it is contracting, which could indicate weakening momentum. RSI is at 75.007, suggesting the stock is nearing overbought territory. Key resistance levels are at 103.031 and 105.306, while support levels are at 95.666 and 93.391. The pre-market price of $102.45 is close to the first resistance level, indicating limited immediate upside potential.
Hedge funds are significantly increasing their positions, with a 640.85% increase in buying over the last quarter.
Strong financial performance in Q4 2025, with revenue up 15.34% YoY, net income up 44.42% YoY, and EPS up 52.52% YoY.
Analysts have mixed ratings, with some lowering price targets due to increased EPS uncertainty and rising costs of equity.
The stock has a 60% chance of declining by -1.94% in the next day, -10.07% in the next week, and -10.95% in the next month based on historical patterns.
No recent news or significant insider trading activity to act as a positive catalyst.
In Q4 2025, Texas Capital Bancshares reported strong financial growth: Revenue increased by 15.34% YoY to $317.47 million, net income rose by 44.42% YoY to $96.35 million, and EPS grew by 52.52% YoY to $2.12. These results indicate robust operational performance and effective cost management.
Analyst ratings are mixed. While some firms like Keefe Bruyette and Stephens raised price targets and maintain positive ratings, others like JPMorgan and Barclays lowered targets and maintain underweight ratings. The average price target ranges from $88 to $114, with recent reductions reflecting macroeconomic concerns and sector-specific challenges.
